COVID-19 induced thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus: A rare case report

This article indicates that the patient suffers from both long-standing underlying diseases and the sudden occurrence of SARS-CoV-2 infection, which complicates the determination of the etiology and diagnosis of TTP. Consequently, after thorough analysis of the disease progression, clinical manifestations, laboratory results, and treatment outcomes, it was primarily concluded that COVID-19 was the catalyst for the onset of TTP in this patient.